Over the coming years, accelerating progress against cancer will be associated with an
increased number of patients who require life-sustaining therapies for infectious or toxic …

Combined advances in haematopoietic cell transplantation (HCT) and intensive care
management have improved the survival of patients with haematological malignancies …

Purpose The question of whether cancer patients with severe respiratory failure benefit from
veno-venous extracorporeal membrane oxygenation (vv-ECMO) remains unanswered. We …

(1) Background: Extracorporeal membrane oxygenation (ECMO) is increasingly used for
acute respiratory failure with few absolute but many relative contraindications. The provider …

Haematopoietic stem cell transplantation (HSCT) is an established treatment for a variety of
malignant and nonmalignant conditions. Pulmonary complications, both infectious and …

Rationale: Because encouraging rates for hospital and long-term survival of
immunocompromised patients in ICUs have been described, these patients are more likely …

To respond to the legitimate questions raised by the application of invasive methods of
monitoring and life-support techniques in cancer patients admitted in the ICU, the European …

Chronic graft-vs-host-disease (cGvHD) is the most relevant long-term complication after
allogeneic stem cell transplantation (HSCT) with major impact on non-relapse mortality, but …

Acute respiratory distress syndrome (ARDS) is a life-threatening lung disease. It may occur
during the pancytopenia phase following allogeneic hematopoietic cell transplantation …

Background Outcomes for patients with oncologic disease and/or after hematopoietic stem
cell transplant (HSCT) requiring intensive care unit admission have improved, but …